Dr. Maxwell V. Meng, MD

Dr. Meng practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Meng's NPI, 1801824024, was assigned on June 28, 2006. Dr. Meng graduated from Johns Hopkins University School of Medicine in 1995. Dr. Meng holds California license A62995.

Dr. Meng's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Meng's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. Dr. Meng is also affiliated with Adventist Health Mendocino Coast. The medical group on file is UCSF Medical Group. Dmand AI also links Dr. Meng to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Meng practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Meng's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Meng is board certified in urology by the American Board of Urology. Dr. Meng is licensed in California.

Dmand AI lists bladder removal, enlarged prostate, enlarged prostate transurethral surgery (TURP), kidney cysts, kidney removal surgery, kidney stone disease, kidney stones and prostate cancer among the conditions Dr. Meng treats.

CMS data shows 656 Medicare services from Dr. Meng across 10 procedure codes in 2024, for 373 Medicare patients. Medicare paid $63,519 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 373 Medicare patients who saw Dr. Meng in 2024. The largest group is 65 to 74, with 179 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 20% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Meng's median patient age at 71, with 18% women.

In 2024, Dr. Meng wrote 184 Medicare Part D claims for 58 patients. 97% of them were for generic drugs. CMS names the drug for 131 of them, across 3 drugs with 11 or more claims each, at $2,181 in total drug cost. In 2023, CMS named 90 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Meng for performance year 2024, reported as part of a group. Dr. Meng accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Meng as offering telehealth. CMS counts 11 procedures of prostate resection by Dr. Meng, more than 60% of the clinicians it reports for that procedure.

Dmand AI links 192 papers to Dr. Meng, published from 2005 to 2025. 2020 was the busiest year, with 8. The most frequent topics are Prostatic Neoplasms, Laparoscopy and Nephrectomy. Dr. Meng has published most often in J Urol. Dr. Meng's most frequent co-authors are Peter R. Carroll, MD, Marshall L. Stoller, MD and Sima Prabodh Porten, MD.

Dmand AI links Dr. Meng to 1 clinical trial. Conditions studied include Adenoviridae Infections and Carcinoma, Transitional Cell.

CMS Open Payments shows 40 general payments to Dr. Meng from 7 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 92% of the total. Intuitive Surgical, Inc. paid the most, $53,725.

Dmand AI lists 3 awards for Dr. Meng, most recently Regional Top Doctor in 2014.

Dr. Meng graduated from Johns Hopkins University School of Medicine in 1995. Dr. Meng is a member of ACS.

Dr. Meng is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.